ARTICLE | Clinical News
Cambridge Biostability, Lipoxen preclinical data
May 11, 2009 7:00 AM UTC
In mice, ImuXen from Lipoxen increased the efficacy of influenza vaccines by about 30-fold, and a VitRIS-stablized formulation enhanced efficacy of the vaccine by a further 4-fold. Lipoxen's ImuXen co...